- Home
- About Us
- Products
- Our Capabilities
- Services
- Contract Development and Manufacturing Organisation {CDMO)
- Contract Manufacturing (CMO]
- Contract Research (CRO)
- Custom Synthesis / Third— Party Manufacturing
- DMF Preparation
- Formulation Research & Development (FR&D)
- Global Marketing Representation
- Market Research & Business Intelligence
- Quality Control (QC) Auditing
- Strategic Marketing
- Supply Chain Management
- Technology Transfer & Scale Up
- Business Partners
- Contact Us
Quinapril HCl
CAS NO : 82586-55-8
THERAPEUTIC CATEGORY : Antihypertensives
Quinapyramine Chloride
CAS NO : 23609-65-6
THERAPEUTIC CATEGORY : Veterinary Anti – Protozoan
QuinapyramineSulphate
CAS NO : 23609-66-7
THERAPEUTIC CATEGORY : Veterinary Anti – Protozoan
Quinoline-4-Carboxylic Acid
CAS NO : 486-74-8
Quinoline-6-Carboxylic Acid
CAS NO : 10349-57-2
Quinuclidine-2-Carboxylic Acid .HCl
CAS NO : 52601-23-7
Quizalofop Ethyl Technical
CAS NO : 76578-14-8
CATEGORY : Herbicides
R-(+)-3-Aminoquinuclidine-Dihydrochloride
CAS NO : 123536-14-1
R)-Boroleu-(+)-pinanediol-trifluoroacetate
API : Bortezomib
CAS NO : 179324-87-9
IMPURUTY NAME : Bortezomib Amino R Isomer (TFA salt)
Rabeprazole + Diclofenac Sodium SR
USAGE : Gastro Intestinal Drugs & Combinations
TYPE : Sustained Release /Controlled Release /Timed Release Pellets
Rabeprazole + Domperidone SR
USAGE : Gastro Intestinal Drugs & Combinations
TYPE : Sustained Release /Controlled Release /Timed Release Pellets
Rabeprazole + Itopride SR
USAGE : Gastro Intestinal Drugs & Combinations
TYPE : Sustained Release /Controlled Release /Timed Release Pellets
Rabeprazole 20 Mg
CATEGORY : Gastroenterology
Rabeprazole Base
CAS NO : 117976-89-3
THERAPEUTIC CATEGORY : Antiulcerative
Rabeprazole Base
CAS NO : 117976-89-3
THERAPEUTIC CATEGORY : Antiulcerative
Rabeprazole EC + Zinc Carnosine
TYPE : Sustained Release /Controlled Release /Timed Release Pellets